nodes	percent_of_prediction	percent_of_DWPC	metapath
Isradipine—CYP3A4—breast cancer	0.204	1	CbGaD
Isradipine—CYP3A4—Exemestane—breast cancer	0.0452	0.133	CbGbCtD
Isradipine—CYP3A4—Letrozole—breast cancer	0.0384	0.113	CbGbCtD
Isradipine—CYP3A4—Anastrozole—breast cancer	0.0342	0.101	CbGbCtD
Isradipine—CYP3A4—Toremifene—breast cancer	0.0313	0.0921	CbGbCtD
Isradipine—CYP3A4—Fulvestrant—breast cancer	0.0291	0.0856	CbGbCtD
Isradipine—CYP3A4—Thiotepa—breast cancer	0.026	0.0763	CbGbCtD
Isradipine—CYP3A4—Ixabepilone—breast cancer	0.0237	0.0698	CbGbCtD
Isradipine—CYP3A4—Lapatinib—breast cancer	0.0229	0.0672	CbGbCtD
Isradipine—CYP3A4—Raloxifene—breast cancer	0.0173	0.0509	CbGbCtD
Isradipine—CYP3A4—Vinorelbine—breast cancer	0.0127	0.0373	CbGbCtD
Isradipine—CYP3A4—Tamoxifen—breast cancer	0.0114	0.0336	CbGbCtD
Isradipine—CYP3A4—Mitoxantrone—breast cancer	0.0112	0.0328	CbGbCtD
Isradipine—CYP3A4—Paclitaxel—breast cancer	0.00891	0.0262	CbGbCtD
Isradipine—CYP3A4—Irinotecan—breast cancer	0.00879	0.0258	CbGbCtD
Isradipine—CYP3A4—Vinblastine—breast cancer	0.00781	0.023	CbGbCtD
Isradipine—CYP3A4—Docetaxel—breast cancer	0.00644	0.0189	CbGbCtD
Isradipine—CYP3A4—Doxorubicin—breast cancer	0.0048	0.0141	CbGbCtD
Isradipine—CACNA2D2—mammary gland—breast cancer	0.00417	0.0965	CbGeAlD
Isradipine—CACNA2D1—mammary gland—breast cancer	0.003	0.0694	CbGeAlD
Isradipine—CACNA2D2—pituitary gland—breast cancer	0.00189	0.0436	CbGeAlD
Isradipine—CACNA2D2—adrenal gland—breast cancer	0.00169	0.039	CbGeAlD
Isradipine—CACNA1H—uterus—breast cancer	0.00156	0.036	CbGeAlD
Isradipine—CACNA1H—pituitary gland—breast cancer	0.00153	0.0354	CbGeAlD
Isradipine—CACNA2D2—endocrine gland—breast cancer	0.00146	0.0338	CbGeAlD
Isradipine—CACNB2—pituitary gland—breast cancer	0.00144	0.0334	CbGeAlD
Isradipine—CACNA1H—female reproductive system—breast cancer	0.0014	0.0324	CbGeAlD
Isradipine—CACNA1H—adrenal gland—breast cancer	0.00137	0.0316	CbGeAlD
Isradipine—CACNA2D1—adipose tissue—breast cancer	0.00135	0.0312	CbGeAlD
Isradipine—CACNB2—adrenal gland—breast cancer	0.00129	0.0298	CbGeAlD
Isradipine—CACNA1H—female gonad—breast cancer	0.00127	0.0295	CbGeAlD
Isradipine—CACNA1D—pituitary gland—breast cancer	0.00126	0.0292	CbGeAlD
Isradipine—CACNA2D1—adrenal gland—breast cancer	0.00121	0.028	CbGeAlD
Isradipine—CACNA1H—endocrine gland—breast cancer	0.00119	0.0274	CbGeAlD
Isradipine—CACNA2D1—bone marrow—breast cancer	0.00117	0.0271	CbGeAlD
Isradipine—CACNA1C—pituitary gland—breast cancer	0.00117	0.027	CbGeAlD
Isradipine—CACNA1C—adipose tissue—breast cancer	0.00116	0.0268	CbGeAlD
Isradipine—CACNA2D1—female gonad—breast cancer	0.00113	0.0261	CbGeAlD
Isradipine—CACNA1D—adrenal gland—breast cancer	0.00113	0.0261	CbGeAlD
Isradipine—CACNA1C—female reproductive system—breast cancer	0.00107	0.0247	CbGeAlD
Isradipine—CACNA2D1—endocrine gland—breast cancer	0.00105	0.0243	CbGeAlD
Isradipine—CACNA1C—adrenal gland—breast cancer	0.00104	0.0241	CbGeAlD
Isradipine—CACNA2D2—lymph node—breast cancer	0.00101	0.0234	CbGeAlD
Isradipine—CACNA1D—endocrine gland—breast cancer	0.000978	0.0226	CbGeAlD
Isradipine—Nimodipine—AHR—breast cancer	0.000976	0.187	CrCbGaD
Isradipine—CACNA1C—endocrine gland—breast cancer	0.000903	0.0209	CbGeAlD
Isradipine—CACNA1H—lymph node—breast cancer	0.000819	0.0189	CbGeAlD
Isradipine—CACNB2—lymph node—breast cancer	0.000774	0.0179	CbGeAlD
Isradipine—CACNA2D1—lymph node—breast cancer	0.000727	0.0168	CbGeAlD
Isradipine—CACNA1D—lymph node—breast cancer	0.000676	0.0156	CbGeAlD
Isradipine—CACNA1C—lymph node—breast cancer	0.000624	0.0144	CbGeAlD
Isradipine—Clevidipine—BCHE—breast cancer	0.000443	0.0848	CrCbGaD
Isradipine—CYP3A4—female reproductive system—breast cancer	0.000394	0.00911	CbGeAlD
Isradipine—CYP3A4—endocrine gland—breast cancer	0.000333	0.00771	CbGeAlD
Isradipine—Amlodipine—CYP1A1—breast cancer	0.000252	0.0483	CrCbGaD
Isradipine—Clevidipine—CYP2D6—breast cancer	0.000243	0.0465	CrCbGaD
Isradipine—Nifedipine—CYP1A1—breast cancer	0.000226	0.0432	CrCbGaD
Isradipine—Clevidipine—CYP3A4—breast cancer	0.000209	0.0399	CrCbGaD
Isradipine—Nisoldipine—CYP3A4—breast cancer	0.0002	0.0383	CrCbGaD
Isradipine—Nimodipine—CYP3A4—breast cancer	0.000193	0.037	CrCbGaD
Isradipine—Amlodipine—CYP2D6—breast cancer	0.000188	0.0359	CrCbGaD
Isradipine—Nitrendipine—CYP3A4—breast cancer	0.000187	0.0358	CrCbGaD
Isradipine—Nilvadipine—CYP3A4—breast cancer	0.000187	0.0358	CrCbGaD
Isradipine—Felodipine—CYP2D6—breast cancer	0.000174	0.0332	CrCbGaD
Isradipine—Nifedipine—CYP2D6—breast cancer	0.000168	0.0321	CrCbGaD
Isradipine—Nisoldipine—ABCB1—breast cancer	0.000167	0.0319	CrCbGaD
Isradipine—Nicardipine—CYP2D6—breast cancer	0.000165	0.0316	CrCbGaD
Isradipine—Amlodipine—CYP3A4—breast cancer	0.000161	0.0308	CrCbGaD
Isradipine—Nitrendipine—ABCB1—breast cancer	0.000156	0.0298	CrCbGaD
Isradipine—Felodipine—CYP3A4—breast cancer	0.000149	0.0285	CrCbGaD
Isradipine—Nifedipine—CYP3A4—breast cancer	0.000144	0.0276	CrCbGaD
Isradipine—Nicardipine—CYP3A4—breast cancer	0.000142	0.0271	CrCbGaD
Isradipine—Amlodipine—ABCB1—breast cancer	0.000134	0.0257	CrCbGaD
Isradipine—Felodipine—ABCB1—breast cancer	0.000124	0.0237	CrCbGaD
Isradipine—Nifedipine—ABCB1—breast cancer	0.00012	0.0229	CrCbGaD
Isradipine—Nicardipine—ABCB1—breast cancer	0.000118	0.0226	CrCbGaD
Isradipine—Diarrhoea—Fluorouracil—breast cancer	8.65e-05	0.000298	CcSEcCtD
Isradipine—Thrombocytopenia—Capecitabine—breast cancer	8.65e-05	0.000298	CcSEcCtD
Isradipine—Tachycardia—Capecitabine—breast cancer	8.62e-05	0.000297	CcSEcCtD
Isradipine—Hypoaesthesia—Epirubicin—breast cancer	8.62e-05	0.000297	CcSEcCtD
Isradipine—Cardiac disorder—Methotrexate—breast cancer	8.59e-05	0.000296	CcSEcCtD
Isradipine—Skin disorder—Capecitabine—breast cancer	8.58e-05	0.000296	CcSEcCtD
Isradipine—Urinary tract disorder—Epirubicin—breast cancer	8.56e-05	0.000295	CcSEcCtD
Isradipine—Urticaria—Paclitaxel—breast cancer	8.55e-05	0.000295	CcSEcCtD
Isradipine—Hyperhidrosis—Capecitabine—breast cancer	8.54e-05	0.000294	CcSEcCtD
Isradipine—Oedema peripheral—Epirubicin—breast cancer	8.54e-05	0.000294	CcSEcCtD
Isradipine—Hypotension—Docetaxel—breast cancer	8.53e-05	0.000294	CcSEcCtD
Isradipine—Connective tissue disorder—Epirubicin—breast cancer	8.52e-05	0.000293	CcSEcCtD
Isradipine—Urethral disorder—Epirubicin—breast cancer	8.49e-05	0.000293	CcSEcCtD
Isradipine—Hepatobiliary disease—Doxorubicin—breast cancer	8.45e-05	0.000291	CcSEcCtD
Isradipine—Angiopathy—Methotrexate—breast cancer	8.4e-05	0.000289	CcSEcCtD
Isradipine—Vomiting—Irinotecan—breast cancer	8.39e-05	0.000289	CcSEcCtD
Isradipine—Vomiting—Mitoxantrone—breast cancer	8.39e-05	0.000289	CcSEcCtD
Isradipine—Immune system disorder—Methotrexate—breast cancer	8.36e-05	0.000288	CcSEcCtD
Isradipine—Dizziness—Fluorouracil—breast cancer	8.36e-05	0.000288	CcSEcCtD
Isradipine—Visual impairment—Epirubicin—breast cancer	8.35e-05	0.000288	CcSEcCtD
Isradipine—Mediastinal disorder—Methotrexate—breast cancer	8.34e-05	0.000288	CcSEcCtD
Isradipine—Rash—Irinotecan—breast cancer	8.32e-05	0.000287	CcSEcCtD
Isradipine—Rash—Mitoxantrone—breast cancer	8.32e-05	0.000287	CcSEcCtD
Isradipine—Dermatitis—Irinotecan—breast cancer	8.32e-05	0.000287	CcSEcCtD
Isradipine—Dermatitis—Mitoxantrone—breast cancer	8.32e-05	0.000287	CcSEcCtD
Isradipine—Musculoskeletal discomfort—Docetaxel—breast cancer	8.32e-05	0.000287	CcSEcCtD
Isradipine—Headache—Mitoxantrone—breast cancer	8.27e-05	0.000285	CcSEcCtD
Isradipine—Headache—Irinotecan—breast cancer	8.27e-05	0.000285	CcSEcCtD
Isradipine—Hypotension—Capecitabine—breast cancer	8.26e-05	0.000285	CcSEcCtD
Isradipine—Insomnia—Docetaxel—breast cancer	8.26e-05	0.000284	CcSEcCtD
Isradipine—Paraesthesia—Docetaxel—breast cancer	8.2e-05	0.000282	CcSEcCtD
Isradipine—Vomiting—Gemcitabine—breast cancer	8.18e-05	0.000282	CcSEcCtD
Isradipine—Bradycardia—Doxorubicin—breast cancer	8.16e-05	0.000281	CcSEcCtD
Isradipine—Dyspnoea—Docetaxel—breast cancer	8.14e-05	0.00028	CcSEcCtD
Isradipine—Somnolence—Docetaxel—breast cancer	8.11e-05	0.00028	CcSEcCtD
Isradipine—Mental disorder—Methotrexate—breast cancer	8.11e-05	0.00028	CcSEcCtD
Isradipine—Rash—Gemcitabine—breast cancer	8.11e-05	0.000279	CcSEcCtD
Isradipine—Dermatitis—Gemcitabine—breast cancer	8.1e-05	0.000279	CcSEcCtD
Isradipine—Eye disorder—Epirubicin—breast cancer	8.1e-05	0.000279	CcSEcCtD
Isradipine—Malnutrition—Methotrexate—breast cancer	8.06e-05	0.000278	CcSEcCtD
Isradipine—Headache—Gemcitabine—breast cancer	8.06e-05	0.000278	CcSEcCtD
Isradipine—Musculoskeletal discomfort—Capecitabine—breast cancer	8.05e-05	0.000277	CcSEcCtD
Isradipine—Flushing—Epirubicin—breast cancer	8.04e-05	0.000277	CcSEcCtD
Isradipine—Cardiac disorder—Epirubicin—breast cancer	8.04e-05	0.000277	CcSEcCtD
Isradipine—Vomiting—Fluorouracil—breast cancer	8.04e-05	0.000277	CcSEcCtD
Isradipine—Dyspepsia—Docetaxel—breast cancer	8.03e-05	0.000277	CcSEcCtD
Isradipine—Hepatitis—Doxorubicin—breast cancer	8.02e-05	0.000276	CcSEcCtD
Isradipine—Insomnia—Capecitabine—breast cancer	7.99e-05	0.000275	CcSEcCtD
Isradipine—Hypoaesthesia—Doxorubicin—breast cancer	7.98e-05	0.000275	CcSEcCtD
Isradipine—Rash—Fluorouracil—breast cancer	7.97e-05	0.000275	CcSEcCtD
Isradipine—Dermatitis—Fluorouracil—breast cancer	7.97e-05	0.000275	CcSEcCtD
Isradipine—Paraesthesia—Capecitabine—breast cancer	7.94e-05	0.000273	CcSEcCtD
Isradipine—Decreased appetite—Docetaxel—breast cancer	7.93e-05	0.000273	CcSEcCtD
Isradipine—Headache—Fluorouracil—breast cancer	7.92e-05	0.000273	CcSEcCtD
Isradipine—Urinary tract disorder—Doxorubicin—breast cancer	7.92e-05	0.000273	CcSEcCtD
Isradipine—Oedema peripheral—Doxorubicin—breast cancer	7.9e-05	0.000272	CcSEcCtD
Isradipine—Gastrointestinal disorder—Docetaxel—breast cancer	7.88e-05	0.000272	CcSEcCtD
Isradipine—Connective tissue disorder—Doxorubicin—breast cancer	7.88e-05	0.000272	CcSEcCtD
Isradipine—Dyspnoea—Capecitabine—breast cancer	7.88e-05	0.000271	CcSEcCtD
Isradipine—Fatigue—Docetaxel—breast cancer	7.87e-05	0.000271	CcSEcCtD
Isradipine—Angiopathy—Epirubicin—breast cancer	7.86e-05	0.000271	CcSEcCtD
Isradipine—Urethral disorder—Doxorubicin—breast cancer	7.86e-05	0.000271	CcSEcCtD
Isradipine—Nausea—Mitoxantrone—breast cancer	7.84e-05	0.00027	CcSEcCtD
Isradipine—Nausea—Irinotecan—breast cancer	7.84e-05	0.00027	CcSEcCtD
Isradipine—Immune system disorder—Epirubicin—breast cancer	7.83e-05	0.00027	CcSEcCtD
Isradipine—Mediastinal disorder—Epirubicin—breast cancer	7.81e-05	0.000269	CcSEcCtD
Isradipine—Constipation—Docetaxel—breast cancer	7.81e-05	0.000269	CcSEcCtD
Isradipine—Back pain—Methotrexate—breast cancer	7.8e-05	0.000269	CcSEcCtD
Isradipine—Dyspepsia—Capecitabine—breast cancer	7.78e-05	0.000268	CcSEcCtD
Isradipine—Visual impairment—Doxorubicin—breast cancer	7.73e-05	0.000266	CcSEcCtD
Isradipine—Asthenia—Paclitaxel—breast cancer	7.73e-05	0.000266	CcSEcCtD
Isradipine—Decreased appetite—Capecitabine—breast cancer	7.68e-05	0.000265	CcSEcCtD
Isradipine—Nausea—Gemcitabine—breast cancer	7.64e-05	0.000263	CcSEcCtD
Isradipine—Gastrointestinal disorder—Capecitabine—breast cancer	7.63e-05	0.000263	CcSEcCtD
Isradipine—Fatigue—Capecitabine—breast cancer	7.62e-05	0.000263	CcSEcCtD
Isradipine—Pruritus—Paclitaxel—breast cancer	7.62e-05	0.000263	CcSEcCtD
Isradipine—Vision blurred—Methotrexate—breast cancer	7.6e-05	0.000262	CcSEcCtD
Isradipine—Mental disorder—Epirubicin—breast cancer	7.59e-05	0.000262	CcSEcCtD
Isradipine—Constipation—Capecitabine—breast cancer	7.56e-05	0.00026	CcSEcCtD
Isradipine—Malnutrition—Epirubicin—breast cancer	7.54e-05	0.00026	CcSEcCtD
Isradipine—Feeling abnormal—Docetaxel—breast cancer	7.52e-05	0.000259	CcSEcCtD
Isradipine—Nausea—Fluorouracil—breast cancer	7.51e-05	0.000259	CcSEcCtD
Isradipine—Eye disorder—Doxorubicin—breast cancer	7.49e-05	0.000258	CcSEcCtD
Isradipine—Ill-defined disorder—Methotrexate—breast cancer	7.48e-05	0.000258	CcSEcCtD
Isradipine—Anaemia—Methotrexate—breast cancer	7.45e-05	0.000257	CcSEcCtD
Isradipine—Flushing—Doxorubicin—breast cancer	7.44e-05	0.000256	CcSEcCtD
Isradipine—Cardiac disorder—Doxorubicin—breast cancer	7.44e-05	0.000256	CcSEcCtD
Isradipine—Tension—Epirubicin—breast cancer	7.4e-05	0.000255	CcSEcCtD
Isradipine—Diarrhoea—Paclitaxel—breast cancer	7.37e-05	0.000254	CcSEcCtD
Isradipine—Nervousness—Epirubicin—breast cancer	7.33e-05	0.000252	CcSEcCtD
Isradipine—Back pain—Epirubicin—breast cancer	7.3e-05	0.000251	CcSEcCtD
Isradipine—Feeling abnormal—Capecitabine—breast cancer	7.28e-05	0.000251	CcSEcCtD
Isradipine—Angiopathy—Doxorubicin—breast cancer	7.27e-05	0.000251	CcSEcCtD
Isradipine—Malaise—Methotrexate—breast cancer	7.27e-05	0.00025	CcSEcCtD
Isradipine—Muscle spasms—Epirubicin—breast cancer	7.25e-05	0.00025	CcSEcCtD
Isradipine—Immune system disorder—Doxorubicin—breast cancer	7.24e-05	0.00025	CcSEcCtD
Isradipine—Mediastinal disorder—Doxorubicin—breast cancer	7.23e-05	0.000249	CcSEcCtD
Isradipine—Leukopenia—Methotrexate—breast cancer	7.22e-05	0.000249	CcSEcCtD
Isradipine—Dizziness—Paclitaxel—breast cancer	7.12e-05	0.000245	CcSEcCtD
Isradipine—Vision blurred—Epirubicin—breast cancer	7.11e-05	0.000245	CcSEcCtD
Isradipine—Cough—Methotrexate—breast cancer	7.03e-05	0.000242	CcSEcCtD
Isradipine—Mental disorder—Doxorubicin—breast cancer	7.02e-05	0.000242	CcSEcCtD
Isradipine—Urticaria—Capecitabine—breast cancer	7.02e-05	0.000242	CcSEcCtD
Isradipine—Ill-defined disorder—Epirubicin—breast cancer	7e-05	0.000241	CcSEcCtD
Isradipine—Malnutrition—Doxorubicin—breast cancer	6.98e-05	0.000241	CcSEcCtD
Isradipine—Anaemia—Epirubicin—breast cancer	6.97e-05	0.00024	CcSEcCtD
Isradipine—Chest pain—Methotrexate—breast cancer	6.86e-05	0.000236	CcSEcCtD
Isradipine—Arthralgia—Methotrexate—breast cancer	6.86e-05	0.000236	CcSEcCtD
Isradipine—Tension—Doxorubicin—breast cancer	6.85e-05	0.000236	CcSEcCtD
Isradipine—Vomiting—Paclitaxel—breast cancer	6.85e-05	0.000236	CcSEcCtD
Isradipine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	6.82e-05	0.000235	CcSEcCtD
Isradipine—Malaise—Epirubicin—breast cancer	6.8e-05	0.000234	CcSEcCtD
Isradipine—Rash—Paclitaxel—breast cancer	6.79e-05	0.000234	CcSEcCtD
Isradipine—Dermatitis—Paclitaxel—breast cancer	6.78e-05	0.000234	CcSEcCtD
Isradipine—Discomfort—Methotrexate—breast cancer	6.78e-05	0.000234	CcSEcCtD
Isradipine—Nervousness—Doxorubicin—breast cancer	6.78e-05	0.000234	CcSEcCtD
Isradipine—Syncope—Epirubicin—breast cancer	6.76e-05	0.000233	CcSEcCtD
Isradipine—Leukopenia—Epirubicin—breast cancer	6.75e-05	0.000233	CcSEcCtD
Isradipine—Back pain—Doxorubicin—breast cancer	6.75e-05	0.000233	CcSEcCtD
Isradipine—Headache—Paclitaxel—breast cancer	6.75e-05	0.000232	CcSEcCtD
Isradipine—Muscle spasms—Doxorubicin—breast cancer	6.71e-05	0.000231	CcSEcCtD
Isradipine—Palpitations—Epirubicin—breast cancer	6.67e-05	0.00023	CcSEcCtD
Isradipine—Loss of consciousness—Epirubicin—breast cancer	6.63e-05	0.000228	CcSEcCtD
Isradipine—Cough—Epirubicin—breast cancer	6.58e-05	0.000227	CcSEcCtD
Isradipine—Anaphylactic shock—Methotrexate—breast cancer	6.58e-05	0.000227	CcSEcCtD
Isradipine—Vision blurred—Doxorubicin—breast cancer	6.58e-05	0.000227	CcSEcCtD
Isradipine—Asthenia—Docetaxel—breast cancer	6.55e-05	0.000226	CcSEcCtD
Isradipine—Ill-defined disorder—Doxorubicin—breast cancer	6.48e-05	0.000223	CcSEcCtD
Isradipine—Pruritus—Docetaxel—breast cancer	6.46e-05	0.000223	CcSEcCtD
Isradipine—Nervous system disorder—Methotrexate—breast cancer	6.45e-05	0.000222	CcSEcCtD
Isradipine—Anaemia—Doxorubicin—breast cancer	6.45e-05	0.000222	CcSEcCtD
Isradipine—Thrombocytopenia—Methotrexate—breast cancer	6.44e-05	0.000222	CcSEcCtD
Isradipine—Chest pain—Epirubicin—breast cancer	6.42e-05	0.000221	CcSEcCtD
Isradipine—Arthralgia—Epirubicin—breast cancer	6.42e-05	0.000221	CcSEcCtD
Isradipine—Anxiety—Epirubicin—breast cancer	6.4e-05	0.000221	CcSEcCtD
Isradipine—Nausea—Paclitaxel—breast cancer	6.4e-05	0.00022	CcSEcCtD
Isradipine—Skin disorder—Methotrexate—breast cancer	6.39e-05	0.00022	CcSEcCtD
Isradipine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	6.38e-05	0.00022	CcSEcCtD
Isradipine—Hyperhidrosis—Methotrexate—breast cancer	6.36e-05	0.000219	CcSEcCtD
Isradipine—Discomfort—Epirubicin—breast cancer	6.34e-05	0.000219	CcSEcCtD
Isradipine—Asthenia—Capecitabine—breast cancer	6.34e-05	0.000218	CcSEcCtD
Isradipine—Malaise—Doxorubicin—breast cancer	6.29e-05	0.000217	CcSEcCtD
Isradipine—Dry mouth—Epirubicin—breast cancer	6.28e-05	0.000216	CcSEcCtD
Isradipine—Syncope—Doxorubicin—breast cancer	6.26e-05	0.000216	CcSEcCtD
Isradipine—Pruritus—Capecitabine—breast cancer	6.25e-05	0.000215	CcSEcCtD
Isradipine—Leukopenia—Doxorubicin—breast cancer	6.25e-05	0.000215	CcSEcCtD
Isradipine—Diarrhoea—Docetaxel—breast cancer	6.24e-05	0.000215	CcSEcCtD
Isradipine—Palpitations—Doxorubicin—breast cancer	6.17e-05	0.000213	CcSEcCtD
Isradipine—Anaphylactic shock—Epirubicin—breast cancer	6.16e-05	0.000212	CcSEcCtD
Isradipine—Oedema—Epirubicin—breast cancer	6.16e-05	0.000212	CcSEcCtD
Isradipine—Hypotension—Methotrexate—breast cancer	6.15e-05	0.000212	CcSEcCtD
Isradipine—Loss of consciousness—Doxorubicin—breast cancer	6.13e-05	0.000211	CcSEcCtD
Isradipine—Cough—Doxorubicin—breast cancer	6.09e-05	0.00021	CcSEcCtD
Isradipine—Shock—Epirubicin—breast cancer	6.06e-05	0.000209	CcSEcCtD
Isradipine—Diarrhoea—Capecitabine—breast cancer	6.05e-05	0.000208	CcSEcCtD
Isradipine—Nervous system disorder—Epirubicin—breast cancer	6.04e-05	0.000208	CcSEcCtD
Isradipine—Dizziness—Docetaxel—breast cancer	6.04e-05	0.000208	CcSEcCtD
Isradipine—Thrombocytopenia—Epirubicin—breast cancer	6.03e-05	0.000208	CcSEcCtD
Isradipine—Tachycardia—Epirubicin—breast cancer	6.01e-05	0.000207	CcSEcCtD
Isradipine—Musculoskeletal discomfort—Methotrexate—breast cancer	5.99e-05	0.000207	CcSEcCtD
Isradipine—Skin disorder—Epirubicin—breast cancer	5.98e-05	0.000206	CcSEcCtD
Isradipine—Hyperhidrosis—Epirubicin—breast cancer	5.95e-05	0.000205	CcSEcCtD
Isradipine—Insomnia—Methotrexate—breast cancer	5.95e-05	0.000205	CcSEcCtD
Isradipine—Arthralgia—Doxorubicin—breast cancer	5.94e-05	0.000205	CcSEcCtD
Isradipine—Chest pain—Doxorubicin—breast cancer	5.94e-05	0.000205	CcSEcCtD
Isradipine—Anxiety—Doxorubicin—breast cancer	5.92e-05	0.000204	CcSEcCtD
Isradipine—Paraesthesia—Methotrexate—breast cancer	5.91e-05	0.000204	CcSEcCtD
Isradipine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	5.9e-05	0.000203	CcSEcCtD
Isradipine—Discomfort—Doxorubicin—breast cancer	5.87e-05	0.000202	CcSEcCtD
Isradipine—Dyspnoea—Methotrexate—breast cancer	5.86e-05	0.000202	CcSEcCtD
Isradipine—Somnolence—Methotrexate—breast cancer	5.85e-05	0.000202	CcSEcCtD
Isradipine—Dizziness—Capecitabine—breast cancer	5.84e-05	0.000201	CcSEcCtD
Isradipine—Dry mouth—Doxorubicin—breast cancer	5.81e-05	0.0002	CcSEcCtD
Isradipine—Vomiting—Docetaxel—breast cancer	5.8e-05	0.0002	CcSEcCtD
Isradipine—Dyspepsia—Methotrexate—breast cancer	5.79e-05	0.0002	CcSEcCtD
Isradipine—Rash—Docetaxel—breast cancer	5.75e-05	0.000198	CcSEcCtD
Isradipine—Hypotension—Epirubicin—breast cancer	5.75e-05	0.000198	CcSEcCtD
Isradipine—Dermatitis—Docetaxel—breast cancer	5.75e-05	0.000198	CcSEcCtD
Isradipine—Decreased appetite—Methotrexate—breast cancer	5.72e-05	0.000197	CcSEcCtD
Isradipine—Headache—Docetaxel—breast cancer	5.72e-05	0.000197	CcSEcCtD
Isradipine—Oedema—Doxorubicin—breast cancer	5.7e-05	0.000196	CcSEcCtD
Isradipine—Anaphylactic shock—Doxorubicin—breast cancer	5.7e-05	0.000196	CcSEcCtD
Isradipine—Gastrointestinal disorder—Methotrexate—breast cancer	5.68e-05	0.000196	CcSEcCtD
Isradipine—Fatigue—Methotrexate—breast cancer	5.67e-05	0.000195	CcSEcCtD
Isradipine—Vomiting—Capecitabine—breast cancer	5.62e-05	0.000194	CcSEcCtD
Isradipine—Musculoskeletal discomfort—Epirubicin—breast cancer	5.61e-05	0.000193	CcSEcCtD
Isradipine—Shock—Doxorubicin—breast cancer	5.6e-05	0.000193	CcSEcCtD
Isradipine—Nervous system disorder—Doxorubicin—breast cancer	5.59e-05	0.000193	CcSEcCtD
Isradipine—Thrombocytopenia—Doxorubicin—breast cancer	5.58e-05	0.000192	CcSEcCtD
Isradipine—Rash—Capecitabine—breast cancer	5.57e-05	0.000192	CcSEcCtD
Isradipine—Insomnia—Epirubicin—breast cancer	5.57e-05	0.000192	CcSEcCtD
Isradipine—Dermatitis—Capecitabine—breast cancer	5.57e-05	0.000192	CcSEcCtD
Isradipine—Tachycardia—Doxorubicin—breast cancer	5.56e-05	0.000192	CcSEcCtD
Isradipine—Headache—Capecitabine—breast cancer	5.54e-05	0.000191	CcSEcCtD
Isradipine—Skin disorder—Doxorubicin—breast cancer	5.53e-05	0.000191	CcSEcCtD
Isradipine—Paraesthesia—Epirubicin—breast cancer	5.53e-05	0.00019	CcSEcCtD
Isradipine—Hyperhidrosis—Doxorubicin—breast cancer	5.51e-05	0.00019	CcSEcCtD
Isradipine—Dyspnoea—Epirubicin—breast cancer	5.49e-05	0.000189	CcSEcCtD
Isradipine—Somnolence—Epirubicin—breast cancer	5.47e-05	0.000189	CcSEcCtD
Isradipine—Nausea—Docetaxel—breast cancer	5.42e-05	0.000187	CcSEcCtD
Isradipine—Feeling abnormal—Methotrexate—breast cancer	5.42e-05	0.000187	CcSEcCtD
Isradipine—Dyspepsia—Epirubicin—breast cancer	5.42e-05	0.000187	CcSEcCtD
Isradipine—Decreased appetite—Epirubicin—breast cancer	5.35e-05	0.000184	CcSEcCtD
Isradipine—Hypotension—Doxorubicin—breast cancer	5.32e-05	0.000183	CcSEcCtD
Isradipine—Gastrointestinal disorder—Epirubicin—breast cancer	5.31e-05	0.000183	CcSEcCtD
Isradipine—Fatigue—Epirubicin—breast cancer	5.31e-05	0.000183	CcSEcCtD
Isradipine—Constipation—Epirubicin—breast cancer	5.26e-05	0.000181	CcSEcCtD
Isradipine—Nausea—Capecitabine—breast cancer	5.25e-05	0.000181	CcSEcCtD
Isradipine—Urticaria—Methotrexate—breast cancer	5.23e-05	0.00018	CcSEcCtD
Isradipine—Musculoskeletal discomfort—Doxorubicin—breast cancer	5.19e-05	0.000179	CcSEcCtD
Isradipine—Insomnia—Doxorubicin—breast cancer	5.15e-05	0.000178	CcSEcCtD
Isradipine—Paraesthesia—Doxorubicin—breast cancer	5.11e-05	0.000176	CcSEcCtD
Isradipine—Dyspnoea—Doxorubicin—breast cancer	5.08e-05	0.000175	CcSEcCtD
Isradipine—Feeling abnormal—Epirubicin—breast cancer	5.07e-05	0.000175	CcSEcCtD
Isradipine—Somnolence—Doxorubicin—breast cancer	5.06e-05	0.000175	CcSEcCtD
Isradipine—Dyspepsia—Doxorubicin—breast cancer	5.01e-05	0.000173	CcSEcCtD
Isradipine—Decreased appetite—Doxorubicin—breast cancer	4.95e-05	0.000171	CcSEcCtD
Isradipine—Gastrointestinal disorder—Doxorubicin—breast cancer	4.92e-05	0.000169	CcSEcCtD
Isradipine—Fatigue—Doxorubicin—breast cancer	4.91e-05	0.000169	CcSEcCtD
Isradipine—Urticaria—Epirubicin—breast cancer	4.89e-05	0.000169	CcSEcCtD
Isradipine—Constipation—Doxorubicin—breast cancer	4.87e-05	0.000168	CcSEcCtD
Isradipine—Asthenia—Methotrexate—breast cancer	4.72e-05	0.000163	CcSEcCtD
Isradipine—Feeling abnormal—Doxorubicin—breast cancer	4.69e-05	0.000162	CcSEcCtD
Isradipine—Pruritus—Methotrexate—breast cancer	4.65e-05	0.00016	CcSEcCtD
Isradipine—Urticaria—Doxorubicin—breast cancer	4.53e-05	0.000156	CcSEcCtD
Isradipine—Diarrhoea—Methotrexate—breast cancer	4.5e-05	0.000155	CcSEcCtD
Isradipine—Asthenia—Epirubicin—breast cancer	4.42e-05	0.000152	CcSEcCtD
Isradipine—Pruritus—Epirubicin—breast cancer	4.36e-05	0.00015	CcSEcCtD
Isradipine—Dizziness—Methotrexate—breast cancer	4.35e-05	0.00015	CcSEcCtD
Isradipine—Diarrhoea—Epirubicin—breast cancer	4.21e-05	0.000145	CcSEcCtD
Isradipine—Vomiting—Methotrexate—breast cancer	4.18e-05	0.000144	CcSEcCtD
Isradipine—Rash—Methotrexate—breast cancer	4.15e-05	0.000143	CcSEcCtD
Isradipine—Dermatitis—Methotrexate—breast cancer	4.14e-05	0.000143	CcSEcCtD
Isradipine—Headache—Methotrexate—breast cancer	4.12e-05	0.000142	CcSEcCtD
Isradipine—Asthenia—Doxorubicin—breast cancer	4.09e-05	0.000141	CcSEcCtD
Isradipine—Dizziness—Epirubicin—breast cancer	4.07e-05	0.00014	CcSEcCtD
Isradipine—Pruritus—Doxorubicin—breast cancer	4.03e-05	0.000139	CcSEcCtD
Isradipine—Vomiting—Epirubicin—breast cancer	3.91e-05	0.000135	CcSEcCtD
Isradipine—Nausea—Methotrexate—breast cancer	3.91e-05	0.000135	CcSEcCtD
Isradipine—Diarrhoea—Doxorubicin—breast cancer	3.9e-05	0.000134	CcSEcCtD
Isradipine—Rash—Epirubicin—breast cancer	3.88e-05	0.000134	CcSEcCtD
Isradipine—Dermatitis—Epirubicin—breast cancer	3.88e-05	0.000134	CcSEcCtD
Isradipine—Headache—Epirubicin—breast cancer	3.86e-05	0.000133	CcSEcCtD
Isradipine—Dizziness—Doxorubicin—breast cancer	3.77e-05	0.00013	CcSEcCtD
Isradipine—Nausea—Epirubicin—breast cancer	3.66e-05	0.000126	CcSEcCtD
Isradipine—Vomiting—Doxorubicin—breast cancer	3.62e-05	0.000125	CcSEcCtD
Isradipine—Rash—Doxorubicin—breast cancer	3.59e-05	0.000124	CcSEcCtD
Isradipine—Dermatitis—Doxorubicin—breast cancer	3.59e-05	0.000124	CcSEcCtD
Isradipine—Headache—Doxorubicin—breast cancer	3.57e-05	0.000123	CcSEcCtD
Isradipine—Nausea—Doxorubicin—breast cancer	3.38e-05	0.000117	CcSEcCtD
Isradipine—CACNA1S—Developmental Biology—TGFB1—breast cancer	2.48e-05	0.000212	CbGpPWpGaD
Isradipine—CYP3A4—Biological oxidations—NCOA1—breast cancer	2.48e-05	0.000212	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—NCOA1—breast cancer	2.47e-05	0.000212	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—CAV1—breast cancer	2.47e-05	0.000211	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—CYP1B1—breast cancer	2.46e-05	0.000211	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—NCOA2—breast cancer	2.44e-05	0.000209	CbGpPWpGaD
Isradipine—CYP3A4—Biological oxidations—CYP19A1—breast cancer	2.44e-05	0.000209	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—MMP9—breast cancer	2.44e-05	0.000209	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—STK11—breast cancer	2.44e-05	0.000209	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—CYP19A1—breast cancer	2.44e-05	0.000209	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—EGFR—breast cancer	2.43e-05	0.000208	CbGpPWpGaD
Isradipine—CACNA1C—Axon guidance—EGFR—breast cancer	2.43e-05	0.000208	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—HSP90AA1—breast cancer	2.41e-05	0.000206	CbGpPWpGaD
Isradipine—CYP3A4—Metapathway biotransformation—CYP19A1—breast cancer	2.41e-05	0.000206	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—SRC—breast cancer	2.38e-05	0.000204	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—FASN—breast cancer	2.37e-05	0.000203	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—BCHE—breast cancer	2.36e-05	0.000202	CbGpPWpGaD
Isradipine—CACNB2—Axon guidance—HRAS—breast cancer	2.34e-05	0.000201	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—NCOA1—breast cancer	2.34e-05	0.000201	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—SLC5A5—breast cancer	2.33e-05	0.0002	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—VEGFA—breast cancer	2.31e-05	0.000198	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—TNF—breast cancer	2.31e-05	0.000198	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—STK11—breast cancer	2.31e-05	0.000198	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—CYP19A1—breast cancer	2.31e-05	0.000198	CbGpPWpGaD
Isradipine—CACNA1H—Developmental Biology—HRAS—breast cancer	2.3e-05	0.000197	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—KRAS—breast cancer	2.29e-05	0.000197	CbGpPWpGaD
Isradipine—CACNA1C—Axon guidance—KRAS—breast cancer	2.29e-05	0.000197	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—STAT3—breast cancer	2.29e-05	0.000196	CbGpPWpGaD
Isradipine—CYP3A4—Biological oxidations—COMT—breast cancer	2.27e-05	0.000195	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—COMT—breast cancer	2.27e-05	0.000194	CbGpPWpGaD
Isradipine—CYP3A4—Biological oxidations—GSTP1—breast cancer	2.26e-05	0.000194	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—GSTP1—breast cancer	2.26e-05	0.000193	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—SLC2A1—breast cancer	2.25e-05	0.000193	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—NQO1—breast cancer	2.25e-05	0.000193	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—SRC—breast cancer	2.25e-05	0.000193	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—PIK3CG—breast cancer	2.25e-05	0.000193	CbGpPWpGaD
Isradipine—CACNB2—Axon guidance—IL6—breast cancer	2.24e-05	0.000192	CbGpPWpGaD
Isradipine—CYP3A4—Metapathway biotransformation—COMT—breast cancer	2.24e-05	0.000192	CbGpPWpGaD
Isradipine—CYP3A4—Metapathway biotransformation—GSTP1—breast cancer	2.23e-05	0.000191	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—HMOX1—breast cancer	2.22e-05	0.000191	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—ITPR1—breast cancer	2.22e-05	0.00019	CbGpPWpGaD
Isradipine—CACNA1D—Axon guidance—HRAS—breast cancer	2.22e-05	0.00019	CbGpPWpGaD
Isradipine—CACNA1H—Developmental Biology—IL6—breast cancer	2.2e-05	0.000189	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—CYP3A4—breast cancer	2.19e-05	0.000188	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—VEGFA—breast cancer	2.19e-05	0.000188	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—MAPK3—breast cancer	2.19e-05	0.000188	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—CTNNB1—breast cancer	2.19e-05	0.000188	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—STAT3—breast cancer	2.17e-05	0.000186	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—CYP1B1—breast cancer	2.16e-05	0.000185	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—COMT—breast cancer	2.15e-05	0.000184	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—MMP9—breast cancer	2.14e-05	0.000184	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—GSTP1—breast cancer	2.14e-05	0.000183	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—ABCB1—breast cancer	2.14e-05	0.000183	CbGpPWpGaD
Isradipine—CACNA1D—Axon guidance—IL6—breast cancer	2.12e-05	0.000182	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—TGFB1—breast cancer	2.12e-05	0.000182	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—HSP90AA1—breast cancer	2.12e-05	0.000181	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—HMOX1—breast cancer	2.11e-05	0.000181	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—ITPR1—breast cancer	2.1e-05	0.00018	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—TYMS—breast cancer	2.1e-05	0.00018	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—EGFR—breast cancer	2.08e-05	0.000179	CbGpPWpGaD
Isradipine—CYP3A4—Biological oxidations—GSTM1—breast cancer	2.08e-05	0.000178	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—MAPK3—breast cancer	2.07e-05	0.000178	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—PLA2G4A—breast cancer	2.07e-05	0.000178	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—GSTM1—breast cancer	2.07e-05	0.000178	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—NCOR1—breast cancer	2.07e-05	0.000178	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—NCOA1—breast cancer	2.06e-05	0.000176	CbGpPWpGaD
Isradipine—CYP3A4—Metapathway biotransformation—GSTM1—breast cancer	2.05e-05	0.000176	CbGpPWpGaD
Isradipine—CACNA1H—Developmental Biology—AKT1—breast cancer	2.03e-05	0.000174	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—STK11—breast cancer	2.03e-05	0.000174	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—CYP19A1—breast cancer	2.03e-05	0.000174	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—ABCB1—breast cancer	2.02e-05	0.000173	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—TGFB1—breast cancer	2.01e-05	0.000172	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—TYMS—breast cancer	1.99e-05	0.00017	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—GPX1—breast cancer	1.99e-05	0.00017	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—TNF—breast cancer	1.98e-05	0.00017	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—SRC—breast cancer	1.98e-05	0.00017	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—PIK3CD—breast cancer	1.97e-05	0.000169	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—EGFR—breast cancer	1.97e-05	0.000169	CbGpPWpGaD
Isradipine—CYP3A4—Biological oxidations—CYP1A1—breast cancer	1.97e-05	0.000169	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—KRAS—breast cancer	1.97e-05	0.000169	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—CYP1A1—breast cancer	1.97e-05	0.000168	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—PLA2G4A—breast cancer	1.96e-05	0.000168	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—NCOR1—breast cancer	1.96e-05	0.000168	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—GSTM1—breast cancer	1.96e-05	0.000168	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—HRAS—breast cancer	1.95e-05	0.000167	CbGpPWpGaD
Isradipine—CACNA1C—Axon guidance—HRAS—breast cancer	1.95e-05	0.000167	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—ALB—breast cancer	1.95e-05	0.000167	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—ERCC2—breast cancer	1.95e-05	0.000167	CbGpPWpGaD
Isradipine—CYP3A4—Metapathway biotransformation—CYP1A1—breast cancer	1.94e-05	0.000166	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—VEGFA—breast cancer	1.93e-05	0.000165	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—STAT3—breast cancer	1.91e-05	0.000163	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—COMT—breast cancer	1.89e-05	0.000162	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—GPX1—breast cancer	1.88e-05	0.000161	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—TNF—breast cancer	1.88e-05	0.000161	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—GSTP1—breast cancer	1.88e-05	0.000161	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—IL6—breast cancer	1.87e-05	0.00016	CbGpPWpGaD
Isradipine—CACNA1C—Axon guidance—IL6—breast cancer	1.87e-05	0.00016	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—NOS3—breast cancer	1.86e-05	0.00016	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—KRAS—breast cancer	1.86e-05	0.00016	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—CYP1A1—breast cancer	1.86e-05	0.00016	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—HMOX1—breast cancer	1.85e-05	0.000159	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—ITPR1—breast cancer	1.85e-05	0.000158	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—ERCC2—breast cancer	1.85e-05	0.000158	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—MTHFR—breast cancer	1.83e-05	0.000157	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—MAPK3—breast cancer	1.82e-05	0.000156	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—ABCB1—breast cancer	1.78e-05	0.000152	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—TGFB1—breast cancer	1.77e-05	0.000152	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—TYMS—breast cancer	1.74e-05	0.00015	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—MTHFR—breast cancer	1.73e-05	0.000149	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—EGFR—breast cancer	1.73e-05	0.000149	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—NCOR1—breast cancer	1.72e-05	0.000148	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—PLA2G4A—breast cancer	1.72e-05	0.000148	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—GSTM1—breast cancer	1.72e-05	0.000148	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—AKT1—breast cancer	1.72e-05	0.000148	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—PIK3CB—breast cancer	1.72e-05	0.000148	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—PTGS2—breast cancer	1.71e-05	0.000146	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—CAV1—breast cancer	1.69e-05	0.000145	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—HRAS—breast cancer	1.67e-05	0.000143	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—GPX1—breast cancer	1.65e-05	0.000142	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—TNF—breast cancer	1.65e-05	0.000142	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—KRAS—breast cancer	1.64e-05	0.00014	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—CYP1A1—breast cancer	1.64e-05	0.00014	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—ERCC2—breast cancer	1.62e-05	0.000139	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—IL6—breast cancer	1.6e-05	0.000137	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—CAV1—breast cancer	1.6e-05	0.000137	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—HRAS—breast cancer	1.58e-05	0.000136	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—SYNJ2—breast cancer	1.58e-05	0.000136	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—PIK3CG—breast cancer	1.54e-05	0.000132	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—MTHFR—breast cancer	1.52e-05	0.000131	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—IL6—breast cancer	1.52e-05	0.00013	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—PTEN—breast cancer	1.49e-05	0.000127	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—AKT1—breast cancer	1.48e-05	0.000127	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—NDUFS3—breast cancer	1.47e-05	0.000126	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—PIK3CG—breast cancer	1.46e-05	0.000125	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—CAV1—breast cancer	1.41e-05	0.000121	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—AKT1—breast cancer	1.4e-05	0.00012	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—HRAS—breast cancer	1.39e-05	0.000119	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—CHST9—breast cancer	1.38e-05	0.000119	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—PIK3CD—breast cancer	1.35e-05	0.000116	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—ALB—breast cancer	1.34e-05	0.000115	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—IL6—breast cancer	1.33e-05	0.000114	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—COX11—breast cancer	1.31e-05	0.000112	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—PIK3CD—breast cancer	1.28e-05	0.00011	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—PIK3CG—breast cancer	1.28e-05	0.00011	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—NOS3—breast cancer	1.28e-05	0.00011	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—ALB—breast cancer	1.26e-05	0.000108	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—AKT1—breast cancer	1.23e-05	0.000105	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—NOS3—breast cancer	1.21e-05	0.000104	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—SHMT1—breast cancer	1.2e-05	0.000103	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—CDA—breast cancer	1.2e-05	0.000103	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—PIK3CB—breast cancer	1.18e-05	0.000101	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—PTGS2—breast cancer	1.17e-05	0.0001	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—SLC2A5—breast cancer	1.15e-05	9.9e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—SLCO1B1—breast cancer	1.15e-05	9.9e-05	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—PIK3CD—breast cancer	1.13e-05	9.65e-05	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—PIK3CB—breast cancer	1.12e-05	9.58e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—APRT—breast cancer	1.12e-05	9.56e-05	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—ALB—breast cancer	1.11e-05	9.53e-05	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—PTGS2—breast cancer	1.11e-05	9.49e-05	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—NOS3—breast cancer	1.06e-05	9.12e-05	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—PIK3CA—breast cancer	1.05e-05	8.99e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—ESRRA—breast cancer	1.05e-05	8.99e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—ANGPTL4—breast cancer	1.05e-05	8.99e-05	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—PTEN—breast cancer	1.02e-05	8.74e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—HADHB—breast cancer	9.94e-06	8.52e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—GPI—breast cancer	9.94e-06	8.52e-05	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—PIK3CB—breast cancer	9.81e-06	8.41e-05	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—PTGS2—breast cancer	9.72e-06	8.34e-05	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—PTEN—breast cancer	9.65e-06	8.28e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—ALDH7A1—breast cancer	9.48e-06	8.13e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—ALDH1A1—breast cancer	9.48e-06	8.13e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—NME1—breast cancer	9.09e-06	7.8e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—PHGDH—breast cancer	9.09e-06	7.8e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—UMPS—breast cancer	9.09e-06	7.8e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—FHL2—breast cancer	9.09e-06	7.8e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—ADSL—breast cancer	9.09e-06	7.8e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—BRIP1—breast cancer	8.92e-06	7.64e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—LDHB—breast cancer	8.92e-06	7.64e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—HPSE—breast cancer	8.92e-06	7.64e-05	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—AKT1—breast cancer	8.57e-06	7.35e-05	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—PTEN—breast cancer	8.48e-06	7.27e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—HMMR—breast cancer	8.45e-06	7.25e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—GSTA3—breast cancer	8.45e-06	7.25e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—ABCC1—breast cancer	8.45e-06	7.25e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—PPARGC1B—breast cancer	8.19e-06	7.02e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—CA9—breast cancer	7.73e-06	6.63e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—GSTA4—breast cancer	7.73e-06	6.63e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—GPX2—breast cancer	7.53e-06	6.46e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—GSTA2—breast cancer	7.53e-06	6.46e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—GPX4—breast cancer	7.44e-06	6.38e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—SULT1A1—breast cancer	7.44e-06	6.38e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—IDH1—breast cancer	7.27e-06	6.23e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—GSTA1—breast cancer	7.27e-06	6.23e-05	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—PIK3CA—breast cancer	7.19e-06	6.16e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—NAT2—breast cancer	7.19e-06	6.16e-05	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—PIK3CA—breast cancer	6.81e-06	5.84e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—DPYD—breast cancer	6.3e-06	5.4e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—MED12—breast cancer	6.3e-06	5.4e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—ALDOA—breast cancer	6.2e-06	5.32e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—NCOA3—breast cancer	6.02e-06	5.16e-05	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—PIK3CA—breast cancer	5.98e-06	5.13e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—SLC2A2—breast cancer	5.98e-06	5.13e-05	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—AKT1—breast cancer	5.87e-06	5.04e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—MTR—breast cancer	5.86e-06	5.02e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—CPT1A—breast cancer	5.86e-06	5.02e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—ABCG2—breast cancer	5.86e-06	5.02e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—HPGDS—breast cancer	5.75e-06	4.93e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—HBA1—breast cancer	5.71e-06	4.9e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—ACHE—breast cancer	5.57e-06	4.78e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—GSTT1—breast cancer	5.57e-06	4.78e-05	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—AKT1—breast cancer	5.56e-06	4.77e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—CYP17A1—breast cancer	5.27e-06	4.52e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—PTGS1—breast cancer	5.22e-06	4.48e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—ENO1—breast cancer	5.22e-06	4.48e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—CYP2D6—breast cancer	5.12e-06	4.39e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—NCOA2—breast cancer	5.03e-06	4.31e-05	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—AKT1—breast cancer	4.89e-06	4.19e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—FASN—breast cancer	4.87e-06	4.18e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—BCHE—breast cancer	4.85e-06	4.16e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—SLC5A5—breast cancer	4.8e-06	4.11e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—SLC2A1—breast cancer	4.63e-06	3.97e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—NQO1—breast cancer	4.63e-06	3.97e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—CYP1B1—breast cancer	4.44e-06	3.81e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—HSP90AA1—breast cancer	4.35e-06	3.73e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—NCOA1—breast cancer	4.24e-06	3.63e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—STK11—breast cancer	4.17e-06	3.58e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—CYP19A1—breast cancer	4.17e-06	3.58e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—COMT—breast cancer	3.88e-06	3.33e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—GSTP1—breast cancer	3.86e-06	3.31e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—HMOX1—breast cancer	3.81e-06	3.27e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—ITPR1—breast cancer	3.8e-06	3.26e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—ABCB1—breast cancer	3.66e-06	3.14e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—TYMS—breast cancer	3.59e-06	3.08e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—NCOR1—breast cancer	3.55e-06	3.04e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—GSTM1—breast cancer	3.55e-06	3.04e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—PLA2G4A—breast cancer	3.55e-06	3.04e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—GPX1—breast cancer	3.4e-06	2.91e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—CYP1A1—breast cancer	3.36e-06	2.89e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—ERCC2—breast cancer	3.34e-06	2.86e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—MTHFR—breast cancer	3.14e-06	2.69e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—CAV1—breast cancer	2.89e-06	2.48e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—PIK3CG—breast cancer	2.64e-06	2.26e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—PIK3CD—breast cancer	2.32e-06	1.99e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—ALB—breast cancer	2.29e-06	1.96e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—NOS3—breast cancer	2.19e-06	1.88e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—PIK3CB—breast cancer	2.02e-06	1.73e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—PTGS2—breast cancer	2e-06	1.72e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—PTEN—breast cancer	1.75e-06	1.5e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—PIK3CA—breast cancer	1.23e-06	1.06e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—AKT1—breast cancer	1.01e-06	8.62e-06	CbGpPWpGaD
